Write For Us

October 25, 2022: Rishi Sunak, Fetterman, Oz debate, Brittney Griner, Weinstein, Biden COVID vax

Sponsored Post Vitamin D2 Canada Persia
57 Views
Published
October 25, 2022: Rishi Sunak, Fetterman, Oz debate, Griner's appeal rejected, Weinstein trial, Biden COVID vaccine

1. Rishi Sunak said he was not daunted by the scale of the challenge as he became Britain's third prime minister in two months, pledging to restore trust, rebuild confidence and lead the country through an economic crisis.

2. U.S. Senate candidate John Fetterman faces his biggest political test since his May stroke when he debates Republican rival Mehmet Oz in a Pennsylvania race that will help determine whether Democrats keep their razor-thin majority in the chamber.

3. A Russian court dismissed U.S. WNBA basketball star Brittney Griner’s appeal against a nine-year sentence for possessing and smuggling vape cartridges containing cannabis oil.

4. Harvey Weinstein sexually assaulted young women hoping to make it in Hollywood, a Los Angeles prosecutor argued on Monday, while the former producer's attorney said his accusers willingly took part in a "casting couch" culture to boost their careers.

5. U.S. President Joe Biden will receive an updated COVID vaccine while launching a new push to boost the number of Americans, especially seniors, getting the shots ahead of Thanksgiving and the coming winter.

#rishisunak
#uk
#politics
#johnfetterman
#droz
#griner
#brittneygriner
#harveyweinstein
#biden
#covid19
#covid
#vaccine
#morningnews
#headlines
#News
#reuters
#newsfeed

Subscribe: http://smarturl.it/reuterssubscribe

Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.

Get the latest news on: http://reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en
Category
World
Tags
reuters, news, top news
Sign in or sign up to post comments.
Be the first to comment